Identification of human serum cholinesterase variants using the polymerase chain reaction amplification technique.

References 1 Brewerton, T. D., Murphy, D. L., Muefler, E. A. and Jimeraon, D. C. (1988) Clin. Phurmncol. Tker. 43, 605-609 2 Fozard, J. R. (1982) in Drugs and Platelets (Van Zwieten, P. A. and Sehiinbanm, E., eds) (Progress in Pharmacology Vol. 4), pp. 135-146, F&her 3 Fozard, J. R. (1985) in Vuscufur Nevroeffector Mechanisms (Bevan, J. A. et al., eds), pp. 321-328, Elaevier 4 Kimball, R. W., Friedman, A. P. and Valfejo, E. (1960) Neurology 10, 107-111 5 Cnrzon, G., Barrie, M. and Wilkinson, M. I. P. (1969) J. Neural. Neurosurg. Psychiutry 32,555-561 6 Nappi, G., Savoldi, F., Bono, G. and Martignoni, E. (1979) Heuduche 19, 273-277 7 Carroll, J. D. and Hilton, 8. P. (1974) Headache 14,149-156 8 Del Bene, E. et al. (1977) in Heuduche: New Visfus (Si.xteri, F., ed.), pp. lOl109, Biomedical Press 9 Hoyer, D. and Schoeffter, P. (1989) Br. J. Phurmucol. 96,9P 10 Hoyer, D. (1989) in The Peripheral Actions of 5-Hydroxytryptumine (Fozard, Jz;aed.), pp. 72-99, Oxford University